• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多系统萎缩模型。

Models of multiple system atrophy.

机构信息

Department of Anatomy, School of Medicine, Konkuk University, 120 Neungdong-Ro, Gwangjin-gu, Seoul, 05029, South Korea.

Research Institute of Medical Science, Konkuk University, Seoul, 05029, South Korea.

出版信息

Exp Mol Med. 2019 Nov 18;51(11):1-10. doi: 10.1038/s12276-019-0346-8.

DOI:10.1038/s12276-019-0346-8
PMID:31740682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6861264/
Abstract

Multiple system atrophy (MSA) is a neurodegenerative disease with diverse clinical manifestations, including parkinsonism, cerebellar syndrome, and autonomic failure. Pathologically, MSA is characterized by glial cytoplasmic inclusions in oligodendrocytes, which contain fibrillary forms of α-synuclein. MSA is categorized as one of the α-synucleinopathy, and α-synuclein aggregation is thought to be the culprit of the disease pathogenesis. Studies on MSA pathogenesis are scarce relative to studies on the pathogenesis of other synucleinopathies, such as Parkinson's disease and dementia with Lewy bodies. However, recent developments in cellular and animal models of MSA, especially α-synuclein transgenic models, have driven advancements in research on this disease. Here, we review the currently available models of MSA, which include toxicant-induced animal models, α-synuclein-overexpressing cellular models, and mouse models that express α-synuclein specifically in oligodendrocytes through cell type-specific promoters. We will also discuss the results of studies in recently developed transmission mouse models, into which MSA brain extracts were intracerebrally injected. By reviewing the findings obtained from these model systems, we will discuss what we have learned about the disease and describe the strengths and limitations of the models, thereby ultimately providing direction for the design of better models and future research.

摘要

多系统萎缩(MSA)是一种具有多种临床表现的神经退行性疾病,包括帕金森病、小脑综合征和自主神经衰竭。病理学上,MSA 的特征是少突胶质细胞内的神经胶质细胞质包涵体,其中包含α-突触核蛋白的纤维形式。MSA 被归类为α-突触核蛋白病之一,α-突触核蛋白聚集被认为是疾病发病机制的罪魁祸首。与其他突触核蛋白病(如帕金森病和路易体痴呆)的发病机制研究相比,对 MSA 发病机制的研究相对较少。然而,MSA 的细胞和动物模型,特别是α-突触核蛋白转基因模型的最新进展,推动了对该疾病的研究进展。在这里,我们回顾了目前可用的 MSA 模型,包括毒素诱导的动物模型、α-突触核蛋白过表达的细胞模型,以及通过细胞类型特异性启动子在少突胶质细胞中特异性表达α-突触核蛋白的小鼠模型。我们还将讨论最近开发的传播性小鼠模型的研究结果,这些模型中脑内注射了 MSA 脑提取物。通过回顾这些模型系统中获得的发现,我们将讨论我们对该疾病的了解,并描述模型的优势和局限性,从而为更好的模型设计和未来的研究提供方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ff/6861264/5432833a8b1f/12276_2019_346_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ff/6861264/a610619bcdbb/12276_2019_346_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ff/6861264/a1ff8a997cd3/12276_2019_346_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ff/6861264/5432833a8b1f/12276_2019_346_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ff/6861264/a610619bcdbb/12276_2019_346_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ff/6861264/a1ff8a997cd3/12276_2019_346_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ff/6861264/5432833a8b1f/12276_2019_346_Fig3_HTML.jpg

相似文献

1
Models of multiple system atrophy.多系统萎缩模型。
Exp Mol Med. 2019 Nov 18;51(11):1-10. doi: 10.1038/s12276-019-0346-8.
2
Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.多系统萎缩症患者大脑中α-突触核蛋白、帕金蛋白和突触结合蛋白异构体水平的改变。
J Neurochem. 2016 Jan;136(1):172-85. doi: 10.1111/jnc.13392. Epub 2015 Nov 11.
3
Is Multiple System Atrophy a Prion-like Disorder?多系统萎缩是类朊病毒病吗?
Int J Mol Sci. 2021 Sep 18;22(18):10093. doi: 10.3390/ijms221810093.
4
The 'α-synucleinopathy syndicate': multiple system atrophy and Parkinson's disease.“α-突触核蛋白病联盟”:多系统萎缩与帕金森病。
J Neural Transm (Vienna). 2024 Jun;131(6):585-595. doi: 10.1007/s00702-023-02653-2. Epub 2023 May 25.
5
Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology.向大脑注射胶质细胞质内含物会诱发多系统萎缩样病理变化。
Brain. 2022 Apr 29;145(3):1001-1017. doi: 10.1093/brain/awab374.
6
Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.溶酶体反应与α-突触核蛋白病理学的关系在帕金森病和多系统萎缩之间存在差异。
Neurobiol Dis. 2018 Jun;114:140-152. doi: 10.1016/j.nbd.2018.02.019. Epub 2018 Mar 2.
7
Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions.多系统萎缩发病机制的研究进展:聚焦于神经胶质细胞胞质包涵体。
Transl Neurodegener. 2020 Feb 17;9:7. doi: 10.1186/s40035-020-0185-5. eCollection 2020.
8
Multiple System Atrophy: Recent Developments and Future Perspectives.多系统萎缩症:最新进展与未来展望。
Mov Disord. 2019 Nov;34(11):1629-1642. doi: 10.1002/mds.27894. Epub 2019 Nov 6.
9
MOBP and HIP1 in multiple system atrophy: New α-synuclein partners in glial cytoplasmic inclusions implicated in the disease pathogenesis.胶质细胞质内包涵体中与疾病发病机制相关的新α-突触核蛋白伴侣:多系统萎缩中的 MOBP 和 HIP1。
Neuropathol Appl Neurobiol. 2021 Aug;47(5):640-652. doi: 10.1111/nan.12688. Epub 2021 Jan 19.
10
Models of multiple system atrophy.多系统萎缩模型。
Curr Top Behav Neurosci. 2015;22:369-93. doi: 10.1007/7854_2013_269.

引用本文的文献

1
Integrative Analysis of Metabolome and Proteome in the Cerebrospinal Fluid of Patients with Multiple System Atrophy.多系统萎缩患者脑脊液中代谢组和蛋白质组的综合分析
Cells. 2025 Feb 12;14(4):265. doi: 10.3390/cells14040265.
2
Neuronal α-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophy.神经元α-突触核蛋白毒性是多系统萎缩中神经退行性变的关键驱动因素。
Brain. 2025 Jul 7;148(7):2306-2319. doi: 10.1093/brain/awaf030.
3
Oligodendrocytes, the Forgotten Target of Gene Therapy.少突胶质细胞——基因治疗中被遗忘的靶点

本文引用的文献

1
Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines.多系统萎缩朊病毒在两种不同的 Tg(SNCA*A53T)小鼠品系中连续传播后仍保持株型特异性。
Acta Neuropathol. 2019 Mar;137(3):437-454. doi: 10.1007/s00401-019-01959-4. Epub 2019 Jan 28.
2
Oligodendroglial α-synucleinopathy-driven neuroinflammation in multiple system atrophy.少突胶质细胞α-突触核蛋白病驱动的多系统萎缩神经炎症。
Brain Pathol. 2019 May;29(3):380-396. doi: 10.1111/bpa.12678. Epub 2019 Jan 31.
3
Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies.
Cells. 2024 Nov 28;13(23):1973. doi: 10.3390/cells13231973.
4
20S proteasome enhancers prevent cytotoxic tubulin polymerization-promoting protein induced α-synuclein aggregation.20S蛋白酶体增强剂可防止细胞毒性微管蛋白聚合促进蛋白诱导的α-突触核蛋白聚集。
iScience. 2024 Jun 4;27(7):110166. doi: 10.1016/j.isci.2024.110166. eCollection 2024 Jul 19.
5
Nature of Parkinsonian features in multiple system atrophy.多系统萎缩中帕金森氏症特征的本质
J Neurosci Rural Pract. 2024 Apr-Jun;15(2):211-216. doi: 10.25259/JNRP_445_2023. Epub 2023 Dec 16.
6
The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson's Disease: A Promising Therapeutic Approach.天然产物和草药作为帕金森病新型药物的潜力:一种有前途的治疗方法。
Int J Mol Sci. 2024 Jan 15;25(2):1071. doi: 10.3390/ijms25021071.
7
The characteristics and alteration of peripheral immune function in patients with multiple system atrophy.多系统萎缩患者外周免疫功能的特点及变化
Front Neurol. 2023 Sep 13;14:1223076. doi: 10.3389/fneur.2023.1223076. eCollection 2023.
8
Sleep Disorders Associated with Neurodegenerative Diseases.与神经退行性疾病相关的睡眠障碍
Diagnostics (Basel). 2023 Sep 10;13(18):2898. doi: 10.3390/diagnostics13182898.
9
The 'α-synucleinopathy syndicate': multiple system atrophy and Parkinson's disease.“α-突触核蛋白病联盟”:多系统萎缩与帕金森病。
J Neural Transm (Vienna). 2024 Jun;131(6):585-595. doi: 10.1007/s00702-023-02653-2. Epub 2023 May 25.
10
An Update on Parkinson's Disease and its Neurodegenerative Counterparts.帕金森病及其神经退行性对应疾病的最新进展。
Curr Med Chem. 2024;31(19):2770-2787. doi: 10.2174/0929867330666230403085733.
细胞微环境赋予了α-突触核蛋白病中独特的病理性α-突触核蛋白菌株。
Nature. 2018 May;557(7706):558-563. doi: 10.1038/s41586-018-0104-4. Epub 2018 May 9.
4
In vitro models of multiple system atrophy from primary cells to induced pluripotent stem cells.从原代细胞到诱导多能干细胞的多系统萎缩的体外模型。
J Cell Mol Med. 2018 May;22(5):2536-2546. doi: 10.1111/jcmm.13563. Epub 2018 Mar 4.
5
Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.多系统萎缩转基因小鼠模型中的进行性纹状体黑质变性:干预治疗的转化意义。
Acta Neuropathol Commun. 2018 Jan 3;6(1):2. doi: 10.1186/s40478-017-0504-y.
6
The neuropathology of multiple system atrophy and its therapeutic implications.多系统萎缩的神经病理学及其治疗意义。
Auton Neurosci. 2018 May;211:1-6. doi: 10.1016/j.autneu.2017.11.002. Epub 2017 Nov 10.
7
MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy.微小RNA-101调节多系统萎缩中的自噬和少突胶质细胞α-突触核蛋白积累。
Front Mol Neurosci. 2017 Oct 17;10:329. doi: 10.3389/fnmol.2017.00329. eCollection 2017.
8
Multiple system atrophy: experimental models and reality.多系统萎缩:实验模型与现实。
Acta Neuropathol. 2018 Jan;135(1):33-47. doi: 10.1007/s00401-017-1772-0. Epub 2017 Oct 20.
9
Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.新型少突胶质细胞α-突触核蛋白病毒载体模型的多系统萎缩:啮齿动物和非人灵长类动物的研究。
Acta Neuropathol Commun. 2017 Jun 16;5(1):47. doi: 10.1186/s40478-017-0451-7.
10
Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy.病毒介导的少突胶质细胞α-突触核蛋白表达可模拟多系统萎缩。
Mov Disord. 2017 Aug;32(8):1230-1239. doi: 10.1002/mds.27041. Epub 2017 May 29.